An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

After years of rising obesity rates in the US, the numbers dipped slightly during 2023, though experts disagree about the ...

The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise The weight loss drug ...

"FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 drugs, including ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

Harvey Fierstein shared how he lost 120 pounds. He says he is a “great believer” in weight loss drugs like Zepbound and ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...